Lipid droplets in host-pathogen interactions

Clinical Lipidology

Volumn 4, Issue 6, 2009, Pages 791-807

  Bozza, Patricia T ^a   Davila, Heloisa ^b   Almeida, Patricia E ^a   Magalhães, Kelly G ^a   Molinaro, Raphael ^a   Almeida, Cecilia J ^a   Maya Monteiro, Clarissa M ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Eicosanoids; Inflammation; Intracellular pathogen; Lipid bodies; Lipid droplet; LPS; Nuclear receptor; Sepsis; Tuberculosis

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACETYLSALICYLIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CELL NUCLEUS RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; FAT DROPLET; ICOSANOID; MONOCYTE CHEMOTACTIC PROTEIN 1; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR;

BACTERIAL INFECTION; BIOGENESIS; CELL COMPARTMENTALIZATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; LIPID COMPOSITION; LIPID STORAGE; MOLECULAR DYNAMICS; MYCOBACTERIOSIS; NONHUMAN; PARACRINE SIGNALING; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; REGULATORY MECHANISM; REVIEW; SEPSIS;

EID: 77649172006     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.09.63     Document Type: Review

References (159)

1. Bozza PT, Magalhaes KG, Weller PF: Leukocyte lipid bodies - biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791(6), 540-551 (2009).
2. Martin S, Parton RG: Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7(5), 373-378 (2006).
3. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, Londos C: Perilipin, a major hormonally regulated adipocytespecific phosphoprotein associated with the periphery of lipid storage droplets. J. Biol. Chem. 266(17), 11341-11346 (1991).
4. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW: Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 294(2), 309-321 (1998).
5. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ, Londos C: Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid. Res. 38(11), 2249-2263 (1997).
6. Wolins NE, Rubin B, Brasaemle DL: TIP47 associates with lipid droplets. J. Biol. Chem. 276(7), 5101-5108 (2001).
7. Dalen KT, Dahl T, Holter E et al.: LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues. Biochim. Biophys. Acta 1771(2), 210-227 (2007).
8. Wolins NE, Quaynor BK, Skinner JR et al.: OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization. Diabetes 55(12), 3418-3428 (2006).
9. Miura S, Gan JW, Brzostowski J et al.: Functional conservation for lipid storage droplet association among perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J. Biol. Chem. 277(35), 32253-32257 (2002).
10. Londos C, Sztalryd C, Tansey JT, Kimmel AR: Role of PAT proteins in lipid metabolism. Biochimie 87(1), 45-49 (2005).
11. Brasaemle DL: The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48(12), 2547-2559 (2007).
12. Bickel PE, Tansey JT, Welte MA: PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta 1791(6), 419-440 (2009).
13. McGookey DJ, Anderson RG: Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells. J. Cell Biol. 97(4), 1156-1168 (1983).
14. Yu W, Bozza PT, Tzizik DM et al.: Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am. J. Pathol. 152(3), 759-769 (1998).
15. Umlauf E, Csaszar E, Moertelmaier M, Schuetz GJ, Parton RG, Prohaska R: Association of stomatin with lipid bodies. J. Biol. Chem. 279(22), 23699-23709 (2004).
16. Fujimoto Y, Itabe H, Sakai J et al.: Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7. Biochim. Biophys. Acta 1644(1), 47-59 (2004).
17. Liu P, Ying Y, Zhao Y, Mundy DI, Zhu M, Anderson RG: Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J. Biol. Chem. 279(5), 3787-3792 (2004).
18. Brasaemle DL, Dolios G, Shapiro L, Wang R: Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 279(45), 46835-46842 (2004).
19. Wan HC, Melo RC, Jin Z, Dvorak AM, Weller PF: Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J. 21(1), 167-178 (2007).
20. Martin S, Driessen K, Nixon SJ, Zerial M, Parton RG: Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism. J. Biol. Chem. 280(51), 42325-42335 (2005).
21. Ozeki S, Cheng J, Tauchi-Sato K, Hatano N, Taniguchi H, Fujimoto T: Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulumderived membrane. J. Cell Sci. 118(Pt 12), 2601-2611 (2005).
22. Fujimoto T, Kogo H, Ishiguro K, Tauchi K, Nomura R: Caveolin-2 is targeted to lipid droplets, a new 'membrane domain' in the cell. J. Cell Biol. 152(5), 1079-1085 (2001).
23. Pol A, Luetterforst R, Lindsay M, Heino S, Ikonen E, Parton RG: A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell Biol. 152(5), 1057-1070 (2001).
24. Pol A, Martin S, Fernandez MA et al.: Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 15(1), 99-110 (2004).
25. Bostrom P, Andersson L, Rutberg M et al.: SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat. Cell Biol. 9(11), 1286-1293 (2007).
26. Dvorak AM, Weller PF, Harvey VS, Morgan ES, Dvorak HF: Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int. Arch. Allergy Immunol. 101(2), 136-142 (1993).
27. Bozza PT, Yu W, Penrose JF, Morgan ES, Dvorak AM, Weller PF: Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 186(6), 909-920 (1997).
28. Bozza PT, Yu W, Cassara J, Weller PF: Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J. Leukoc. Biol. 64(4), 563-569 (1998).
29. Pacheco P, Bozza FA, Gomes RN et al.: Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 169(11), 6498-6506 (2002).
30. Thore CR, Beasley TC, Busija DW: In vitro and in vivo localization of prostaglandin H synthase in fetal sheep neurons. Neurosci. Lett. 242(1), 29-32 (1998).
31. Meadows JW, Pitzer B, Brockman DE, Myatt L: Expression and localization of adipophilin and perilipin in human fetal membranes: association with lipid bodies and enzymes involved in prostaglandin synthesis. J. Clin. Endocrinol. Metab. 90(4), 2344-2350 (2005).
32. Arend A, Masso R, Masso M, Selstam G: Electron microscope immunocytochemical localization of cyclooxygenase-1 and -2 in pseudopregnant rat corpus luteum during luteolysis. Prostaglandins Other Lipid Mediat, 74(1-4), 1-10 (2004).
33. Moreira LS, Piva B, Gentile LB et al.: Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acidsinduced lipid bodies of epithelial cells. Biochim. Biophys. Acta 1791(3), 156-165 (2009).
34. Wooten RE, Willingham MC, Daniel LW et al.: Novel translocation responses of cytosolic phospholipase A2-a fluorescent proteins. Biochim. Biophys. Acta 1783(8), 1544-1550 (2008).
35. Yu W, Cassara J, Weller PF: Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood 95(3), 1078-1085 (2000).
36. Chen JS, Greenberg AS, Wang SM: Oleic acid-induced PKC isozyme translocation in RAW 264.7 macrophages. J. Cell. Biochem. 86(4), 784-791 (2002).
37. McLauchlan J: Lipid droplets and hepatitis C virus infection. Biochim. Biophys. Acta 1791(6), 552-559 (2009).
38. Murphy DJ: The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40(5), 325-438 (2001).
39. Robenek MJ, Severs NJ, Schlattmann K et al.: Lipids partition caveolin-1 from ER membranes into lipid droplets: updating the model of lipid droplet biogenesis. FASEB J. 18(7), 866-868 (2004).
40. Brown DA: Lipid droplets: proteins floating on a pool of fat. Curr. Biol. 11(11), R446-R449 (2001).
41. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichtenstein LM, Weller PF: Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 40(6), 759-769 (1992).
42. Dvorak AM, Morgan ES, Tzizik DM, Weller PF: Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int. Arch. Allergy Immunol. 105(3), 245-250 (1994).
43. Robenek H, Robenek MJ, Troyer D: PAT family proteins pervade lipid droplet cores. J. Lipid Res. 46(6), 1331-1338 (2005).
44. Dvorak AM: Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. Chem. Immunol. Allergy 85, 252-315 (2005).
45. Dvorak AM, Morgan ES, Weller PF: RNA is closely associated with human mast cell lipid bodies. Histol. Histopathol. 18(3), 943-968 (2003).
46. Beller M, Riedel D, Jansch L et al.: Characterization of the Drosophila lipid droplet subproteome. Mol. Cell. Proteomics 5(6), 1082-1094 (2006).
47. Gronke S, Beller M, Fellert S, Ramakrishnan H, Jackle H, Kuhnlein RP: Control of fat storage by a Drosophila PAT domain protein. Curr. Biol. 13(7), 603-606 (2003).
48. Sato S, Fukasawa M, Yamakawa Y et al.: Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 139(5), 921-930 (2006).
49. Cermelli S, Guo Y, Gross SP, Welte MA: The lipid-droplet proteome reveals that droplets are a protein-storage depot. Curr. Biol. 16(18), 1783-1795 (2006).
50. Binns D, Januszewski T, Chen Y et al.: An intimate collaboration between peroxisomes and lipid bodies. J. Cell Biol. 173(5), 719-731 (2006).
51. Ploegh HL: A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature 448(7152), 435-438 (2007).
52. Guo Y, Cordes KR, Farese RV Jr, Walther TC: Lipid droplets at a glance. J. Cell Sci. 122(Pt 6), 749-752 (2009).
53. Kondo H, Iwasa H, Saino-Saito S: First disclosure of lipid droplet substructure and myelin translucency in embedment-free section electron microscopy. Tohoku J. Exp. Med. 214(3), 167-174 (2008).
54. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT: Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176(5), 3087-3097 (2006).
55. D'Avila H, Almeida PE, Roque NR, Castro-Faria-Neto HC, Bozza PT: Toll-like receptor-2-mediated C-C chemokine receptor 3 and eotaxin-driven eosinophil influx induced by Mycobacterium bovis BCG pleurisy. Infect. Immun. 75(3), 1507-1511 (2007).
56. Pacheco P, Vieira-de-Abreu A, Gomes RN et al.: Monocyte chemoattractant protein-1/ CC chemokine ligand 2 controls microtubuledriven biogenesis and leukotriene B4- synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 179(12), 8500-8508 (2007).
57. Peyron P, Vaubourgeix J, Poquet Y et al.: Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4(11), E1000204 (2008).
58. Bozza PT, Melo RC, Bandeira-Melo C: Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol. Ther. 113(1), 30-49 (2007).
59. Melo RC, D'Avila H, Fabrino DL, Almeida PE, Bozza PT: Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 35(1), 59-67 (2003).
60. D'Avila H, Roque NR, Cardoso RM, Castro-Faria-Neto HC, Melo RC, Bozza PT: Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell Microbiol. 10(12), 2589-2604 (2008).
61. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S: Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3, 352-363 (2008).
62. Takeuchi O, Sato S, Horiuchi T et al.: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169(1), 10-14 (2002).
63. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ: Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163(7), 3920-3927 (1999).
64. Means TK, Jones BW, Schromm AB et al.: Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosisinduced macrophage responses. J. Immunol. 166(6), 4074-4082 (2001).
65. Almeida PE, Silva AR, Maya-Monteiro CM et al. Mycobacterium bovis bacillus Calmette- Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor-g expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 183(2), 1337-1345 (2009).
66. Mattos KA, D'Avila H, Rodrigues LS et al.: Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J. Leukoc. Biol. (2010) (In press).
67. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI: Chlamydia pneumoniae - induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect. Immun. 75(2), 753-759 (2007).
68. Sorgi CA, Secatto A, Fontanari C et al.: Histoplasma capsulatum cell wall b-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection. J. Immunol. 182(7), 4025-4035 (2009).
69. Bandeira-Melo C, Phoofolo M, Weller PF: Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J. Biol. Chem. 276(25), 22779-22787 (2001).
70. Bozza PT, Payne JL, Goulet JL, Weller PF: Mechanisms of platelet-activating factorinduced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 183(4), 1515-1525 (1996).
71. Vieira-de-Abreu A, Assis EF, Gomes GS et al.: Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils. Am. J. Respir. Cell Mol. Biol. 33(3), 254-261 (2005).
72. Silva AR, Pacheco P, Vieira-de-Abreu A et al.: Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta DOI:10.1016/j.bbalip.2009.06.004 (2009) (In press).
73. Silva AR, de Assis EF, Caiado LF et al.: Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J. Immunol. 168(8), 4112-4120 (2002).
74. Gomes RN, Bozza FA, Amancio RT et al.: Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26(1), 41-49 (2006).
75. de Assis EF, Silva AR, Caiado LF et al.: Synergism between platelet-activating factor-like phospholipids and peroxisome proliferatoractivated receptor-g agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. J. Immunol. 171(4), 2090-2098 (2003).
76. Penido C, Vieira-de-Abreu A, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gd T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis Bacille Calmette-Guerin. J. Immunol. 171(12), 6788-6794 (2003).
77. Flynn JL, Chan J: Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
78. Szeles L, Torocsik D, Nagy L: PPAR-g in immunity and inflammation: cell types and diseases. Biochim. Biophys. Acta 1771(8), 1014-1030 (2007).
79. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-g. Cell 93(2), 229-240 (1998).
80. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPAR-g promotes monocyte/ macrophage differentiation and uptake of oxidized LDL. Cell 93(2), 241-252 (1998).
81. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferatoractivated receptor-g is a negative regulator of macrophage activation. Nature 391(6662), 79-82 (1998).
82. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM: PPAR-g dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med, 7(1), 48-52 (2001).
83. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the X-files. Science 294(5548), 1866-1870 (2001).
84. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptorretinoid X receptor heterodimers. Proc. Natl Acad. Sci. USA, 90(6), 2160-2164 (1993).
85. Gearing KL, Gottlicher M, Teboul M, Widmark E, Gustafsson JA: Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl Acad. Sci. USA, 90(4), 1440-1444 (1993).
86. Cruz D, Watson AD, Miller CS et al.: Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 118(8), 2917-2928 (2008).
87. Castrillo A, Joseph SB, Vaidya SA et al.: Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12(4), 805-816 (2003).
88. Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN, McLauchlan J: A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim. Biophys. Acta 1728(1-2), 95-104 (2005).
89. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR: PPAR-g-2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288(6), E1195-E1205 (2005).
90. Larigauderie G, Furman C, Jaye M et al.: Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 24(3), 504-510 (2004).
91. Gao J, Serrero G: Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J. Biol. Chem. 274(24), 16825-16830 (1999).
92. Imamura M, Inoguchi T, Ikuyama S et al.: ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am. J. Physiol. Endocrinol. Metab. 283(4), E775-E783 (2002).
93. Wang SM, Hwang RD, Greenberg AS, Yeo HL: Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes. Histochem. Cell Biol. 120(4), 285-292 (2003).
94. Gross DN, Miyoshi H, Hosaka T et al.: Dynamics of lipid droplet-associated proteins during hormonally stimulated lipolysis in engineered adipocytes: stabilization and lipid droplet binding of adipocyte differentiationrelated protein/adipophilin. Mol. Endocrinol. 20(2), 459-466 (2006).
95. Maya-Monteiro CM, Almeida PE, D'Avila H et al.: Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 283(4), 2203-2210 (2008).
96. Maya-Monteiro CM, Bozza PT: Leptin and mTOR: partners in metabolism and inflammation. Cell Cycle 7(12), 1713-1717 (2008).
97. Chung S, Brown JM, Sandberg MB, McIntosh M: Trans-10, cis-12 CLA increases adipocyte lipolysis and alters lipid dropletassociated proteins: role of mTOR and ERK signaling. J. Lipid Res. 46(5), 885-895 (2005).
98. Xu G, Sztalryd C, Lu X et al.: Posttranslational regulation of adipose differentiation-related protein by the ubiquitin/proteasome pathway. J. Biol. Chem. 280, 42841-42847 (2005).
99. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF: Leukocyte lipid body formation and eicosanoid generation: cyclooxygenaseindependent inhibition by aspirin. Proc. Natl Acad. Sci. USA, 93(20), 11091-11096 (1996).
100. Triggiani M, Oriente A, Seeds MC, Bass DA, Marone G, Chilton FH: Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 182(5), 1181-1190 (1995).
101. Salluh JI, Pino AV, Silva AR et al.: Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury. Prostaglandins Leukot. Essent. Fatty Acids 77(1), 1-8 (2007).
102. Yaqoob P: Fatty acids as gatekeepers of immune cell regulation. Trends Immunol. 24(12), 639-645 (2003).
103. Anderson RG, Jacobson K: A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296(5574), 1821-1825 (2002).
104. Wymann MP, Schneiter R: Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 9(2), 162-176 (2008).
105. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182 (2000).
106. Mandal AK, Skoch J, Bacskai BJ et al.: The membrane organization of leukotriene synthesis. Proc. Natl Acad. Sci. USA, 101(17), 6587-6592 (2004).
107. Peters-Golden M, Brock TG: Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett. 487(3), 323-326 (2001).
108. Diaz BL, Arm JP: Phospholipase A2. Prostaglandins Leukot. Essent. Fatty Acids 69(2-3), 87-97 (2003).
109. Bandeira-Melo C, Weller PF: Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot. Essent. Fatty Acids 69(2-3), 135-143 (2003).
110. Accioly MT, Pacheco P, Maya-Monteiro CM et al.: Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 68(6), 1732-1740 (2008).
111. Weibel GL, Joshi MR, Wei C, Bates SR, Blair IA, Rothblat GH: 15(S)-lipoxygenase-1 associates with neutral lipid droplets in macrophage foam cells: evidence of lipid droplet metabolism. J. Lipid Res. DOI: 10.1194/jlr.M900081-JLR200 (2009).
112. Silva AR, Pacheco P, Vieira-de-Abreu A et al.: Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta 1791(11), 1066-1075 (2009).
113. Weller PF, Bozza PT, Yu W, Dvorak AM: Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 118(2-4), 450-452 (1999).
114. Leite MS, Pacheco P, Gomes RN et al.: Mechanisms of increased survival after lipopolysaccharide-induced endotoxic shock in mice consuming olive oil-enriched diet. Shock 23(2), 173-178 (2005).
115. Stulnig TM, Huber J, Leitinger N et al.: Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 276(40), 37335-37340 (2001).
116. Ma DW, Seo J, Davidson LA et al.: n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 18(9), 1040-1042 (2004).
117. Fan YY, McMurray DN, Ly LH, Chapkin RS: Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J. Nutr. 133(6), 1913-1920 (2003).
118. Fan YY, Ly LH, Barhoumi R, McMurray DN, Chapkin RS: Dietary docosahexaenoic acid suppresses T cell protein kinase C-t lipid raft recruitment and IL-2 production. J. Immunol. 173(10), 6151-6160 (2004).
119. Nanhuck RM, Doublet A, Yaqoob P: Effects of lipid emulsions on lipid body formation and eicosanoid production by human peripheral blood mononuclear and polymorphonuclear cells. Clin. Nutr. 28(5), 556-564 (2009).
120. Phillips RM, Six DA, Dennis EA, Ghosh P: In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 278, 41326-41332 (2003).
121. Saliba AM, Nascimento DO, Silva MC et al.: Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell. Microbiol. 7(12), 1811-1822 (2005).
122. Plotkowski MC, Brandao BA, de Assis MC et al.: Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb. Pathog. 45(1), 30-37 (2008).
123. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM: Ultrastructural immunogold localization of subcellular sites of TNF-a in colonic Crohn's disease. J. Leukoc. Biol. 58(3), 284-298 (1995).
124. Lim KG, Wan HC, Bozza PT et al.: Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J. Immunol. 156(7), 2566-2570 (1996).
125. Dvorak AM, Morgan ES, Weller PF: Ultrastructural immunolocalization of basic fibroblast growth factor to lipid bodies and secretory granules in human mast cells. Histochem. J. 33(7), 397-402 (2001).
126. Assunção-Miranda I, Amaral FA, Bozza FA et al.: Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. DOI: 10.1096/fj.09-139469 (In press).
127. Cardona PJ, Llatjos R, Gordillo S et al.: Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand. J. Immunol. 52(2), 156-163 (2000).
128. Ridley DS, Ridley MJ: Rationale for the histological spectrum of tuberculosis. A basis for classification. Pathology 19(2), 186-192 (1987).
129. Kumar Y, Cocchiaro J, Valdivia RH: The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr. Biol. 16(16), 1646-1651 (2006).
130. Caceres N, Tapia G, Ojanguren I et al.: Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb.), 89(2), 175-182 (2009).
131. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F et al.: Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE, 1, E43 (2006).
132. Tanigawa K, Suzuki K, Nakamura K et al.: Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol. Lett. 289, 72-79 (2008).
133. D'Avila H, Maya-Monteiro CM, Bozza PT: Lipid bodies in innate immune response to bacterial and parasite infections. Int. Immunopharmacol. 8(10), 1308-1315 (2008).
134. Bandeira-Melo C, Weller PF, Bozza PT: EicosaCell - an immunofluorescent-based assay to localize newly synthesized eicosanoid lipid mediators at intracellular sites. Methods Molec. Biol. (2010) (In press).
135. Freire-de-Lima CG, Nascimento DO, Soares MB et al.: Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403(6766), 199-203 (2000).
136. Rangel Moreno J, Estrada Garcia I, De La Luz Garcia Hernandez M, Aguilar Leon D, Marquez R, Hernandez Pando R: The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106(2), 257-266 (2002).
137. Luo M, Fadeev EA, Groves JT: Mycobactinmediated iron acquisition within macrophages. Nat. Chem. Biol. 1(3), 149-153 (2005).
138. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH: Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc. Natl Acad. Sci. USA 105(27), 9379-9384 (2008). nn Describes an active mechanism of transport of lipid droplets into the lumen of a parasitophorous vacuole of Chlamydia trachomatis controlled by pathogen-derived proteins.
139. Rodriguez-Acosta A, Finol HJ, Pulido-Mendez M et al.: Liver ultrastructural pathology in mice infected with Plasmodium berghei. J. Submicrosc. Cytol. Pathol. 30(2), 299-307 (1998).
140. Melo RC, Fabrino DL, Dias FF, Parreira GG: Lipid bodies: structural markers of inflammatory macrophages in innate immunity. Inflamm. Res. 55(8), 342-348 (2006).
141. Coppens I: Contribution of host lipids to Toxoplasma pathogenesis. Cell. Microbiol. 8(1), 1-9 (2006).
142. Pinheiro RO, Nunes MP, Pinheiro CS et al.: Induction of autophagy correlates with increased parasite load of Leishmania amazonensis in BALB/c but not C57BL/6 macrophages. Microbes Infect. 11(2), 181-190 (2009).
143. Deretic V, Levine B: Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5, 527-549 (2009).
144. Fujimoto T, Ohsaki Y: Proteasomal and autophagic pathways converge on lipid droplets. Autophagy 2(4), 299-301 (2006).
145. Ohsaki Y, Cheng J, Fujita A, Tokumoto T, Fujimoto T: Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B. Mol. Biol. Cell 17(6), 2674-2683 (2006).
146. Aliberti J, Bafica A: Anti-inflammatory pathways as a host evasion mechanism for pathogens. Prostaglandins Leukot. Essent. Fatty Acids 73(3-4), 283-288 (2005). (Pubitemid 41253488)
147. Combs TP, Nagajyothi F, Mukherjee S et al.: The adipocyte as an important target cell for Trypanosoma cruzi infection. J. Biol. Chem. 280(25), 24085-24094 (2005).
148. Charron AJ, Sibley LD: Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J. Cell Sci. 115(Pt 15), 3049-3059 (2002).
149. Quittnat F, Nishikawa Y, Stedman TT et al.: On the biogenesis of lipid bodies in ancient eukaryotes: synthesis of triacylglycerols by a Toxoplasma DGAT1- related enzyme. Mol. Biochem. Parasitol. 138(1), 107-122 (2004).
150. Nishikawa Y, Quittnat F, Stedman TT et al.: Host cell lipids control cholesteryl ester synthesis and storage in intracellular Toxoplasma. Cell. Microbiol. 7(6), 849-867 (2005).
151. Jackson KE, Klonis N, Ferguson DJ, Adisa A, Dogovski C, Tilley L: Food vacuole-associated lipid bodies and heterogeneous lipid environments in the malaria parasite, Plasmodium falciparum. Mol. Microbiol. 54(1), 109-122 (2004).
152. Palacpac NM, Hiramine Y, Mi-ichi F et al.: Developmental-stage-specific triacylglycerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium falciparuminfected erythrocytes. J. Cell Sci. 117(Pt 8), 1469-1480 (2004).
153. Vielemeyer O, McIntosh MT, Joiner KA, Coppens I: Neutral lipid synthesis and storage in the intraerythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasitol. 135(2), 197-209 (2004).
154. Coppens I, Vielemeyer O: Insights into unique physiological features of neutral lipids in Apicomplexa: from storage to potential mediation in parasite metabolic activities. Int. J. Parasitol. 35(6), 597-615 (2005).
155. Furlong ST, Thibault KS, Morbelli LM, Quinn JJ, Rogers RA: Uptake and compartmentalization of fluorescent lipid analogs in larval Schistosoma mansoni. J. Lipid Res. 36(1), 1-12 (1995).
156. Gobert GN, Stenzel DJ, Jones MK, McManus DP: Immunolocalization of the fatty acid-binding protein Sj-FABPc within adult Schistosoma japonicum. Parasitology 115(Pt 1), 33-39 (1997).
157. Meyer F, Meyer H, Bueding E: Lipid metabolism in the parasitic and free-living flatworms, Schistosoma mansoni and Dugesia dorotocephala. Biochim. Biophys. Acta 210(2), 257-266 (1970).
158. Stanley RG, Jackson CL, Griffiths K, Doenhoff MJ: Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in mice. Atherosclerosis DOI: 10.1016/j.atherosclerosis.2009.04.037 (2009) (Epub ahead of print).
159. Correa Soares JB, Maya-Monteiro CM, Bittencourt-Cunha PR et al.: Extracellular lipid droplets promote hemozoin crystallization in the gut of the blood fluke Schistosoma mansoni. FEBS Lett. 581(9), 1742-1750 (2007).